CoChat

Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial

Open access

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Blended cognitive behaviour therapy (bCBT) is an effective treatment for fear of cancer recurrence (FCR) in curatively-treated breast, colorectal and prostate cancer survivors with high FCR. However, long-term outcomes are unknown. This study investigated the long-term efficacy and cost-effectiveness of bCBT compared with care as usual (CAU). METHODS: Eighty-eight cancer survivors with high FCR (Cancer Worry Scale ≥14) were randomly assigned to bCBT (n = 45) or CAU (n = 43). Data were collected at baseline and at three, nine and fifteen months from baseline and analysed by modified intention-to-treat. Efficacy was investigated with linear mixed-effects models. Cost-effectiveness was investigated from a societal perspective by comparing costs with quality-adjusted life-years (QALYs). RESULTS: Participants who received bCBT reported significantly lower FCR compared with CAU (mean difference of - 1.787 [95% CI -3.251 to - 0.323, p = 0.017] at 15 months follow-up), and proportionally greater self-rated and clinically significant improvement at each follow-up measurement. Total QALYs were non-significantly different between conditions when adjusted for utility score baseline differences (0.984 compared to 0.957, p = 0.385), while total costs were €631 lower (95% CI -1737 to 2794, p = 0.587). Intervention costs of bCBT were €466. The incremental cost-effectiveness ratio amounted to an additional €2049 per QALY gained, with a 62% probability that bCBT is cost-effective at a willingness to pay (WTP) threshold of €20,000 per QALY. Results were confirmed in sensitivity analyses. CONCLUSIONS: bCBT for cancer survivors with FCR is clinically and statistically more effective than CAU on the long-term. In addition, bCBT is a relatively inexpensive intervention with similar costs and QALYs as CAU. TRIAL REGISTRATION: The RCT was registered in the Dutch National Trial Register ( NTR4423 ) on 12-Feb-2014. This abstract was previously presented at the International Psycho-Oncology Society conference of 2018 and published online. (Psycho-oncology, 27(S3):8-55; 2018).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-019-5615-3

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 CONSORT flow diagram showing recruitment and enrolment of 88 participants. Participants who reported a recurrence, but still filled in questionnaires while they had a recurrence (6 additional patients in the bCBT group), are not listed as ‘lost to follow up’. Abbreviations: bCBT, blended cognitive behaviour therapy; CAU, care as usual; BC, breast cancer; CRC, colorectal cancer; PC, prostate cancer; CWS, cancer worry scale; EQ-5D, EuroQol five dimensions questionnaire
Fig. 1 CONSORT flow diagram showing recruitment and enrolment of 88 participants. Participants who reported a recurrence, but still filled in questionnaires while they had a recurrence (6 additional patients in the bCBT group), are not listed as ‘lost to follow up’. Abbreviations: bCBT, blended cognitive behaviour therapy; CAU, care as usual; BC, breast cancer; CRC, colorectal cancer; PC, prostate cancer; CWS, cancer worry scale; EQ-5D, EuroQol five dimensions questionnaireCC BY · PubMed Central
Fig. 2 Cost-effectiveness acceptability curves of the different cost-effectiveness analyses, showing the probability that the intervention is cost-effective at different willingness to pay (WTP) thresholds. Abbreviations: bCBT, blended cognitive behaviour therapy; QALY, quality-adjusted life year; QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30
Fig. 2 Cost-effectiveness acceptability curves of the different cost-effectiveness analyses, showing the probability that the intervention is cost-effective at different willingness to pay (WTP) thresholds. Abbreviations: bCBT, blended cognitive behaviour therapy; QALY, quality-adjusted life year; QLQ-C30, European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. Humphris G, Rogers S. AFTER and beyond: cancer recurrence fears and a test of an intervention in oral and oropharyngeal patients. Soc Sci Dent. 2012;2:29–38.

Cited by

See all 55

Metadata

Authors
Burm, R., Thewes, B., Rodwell, L., Kievit, W., Speckens, A., van de Wal, M., & Prins, J.
Affiliations
Radboud University Medical Center (NL)
Corresponding author
Burm, Rens
Venue
BMC Cancer
Published
2019-05-16
Volume
19
Issue
1
Pages
462-462
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2947157965
Cited by
55
References
59
Citations by year
2026: 5 · 2025: 7 · 2024: 9 · 2023: 7 · 2022: 13 · 2021: 9 · 2020: 3 · 2019: 2
FWCI
2.82
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
KWF Kankerbestrijding (KUN 2012–5545)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
Keywords
fear of cancer recurrence, cancer survivors, breast cancer, prostate cancer, colorectal cancer, long-term efficacy, cost-effectiveness, quality-adjusted life years, incremental cost-effectiveness ratio, psycho-oncology, intervention costs, willingness-to-pay threshold, societal perspective
MeSH terms
Cancer Survivors, Aged, Breast Neoplasms, Cost-Benefit Analysis, Fear, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Cognitive Behavioral Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12885-019-5615-3
The paper
Burm, R., Thewes, B., Rodwell, L., Kievit, W., Speckens, A., van de Wal, M., & Prins, J. (2019). Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial. BMC Cancer. https://doi.org/10.1186/s12885-019-5615-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.